Status:

COMPLETED

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Lead Sponsor:

Astellas Pharma Inc

Conditions:

Benign Prostatic Hyperplasia

Benign Prostatic Hypertrophy

Eligibility:

MALE

50+ years

Phase:

PHASE4

Brief Summary

To evaluate the efficacy and safety of solifenacin succinate as add-on therapy for overactive bladder (OAB) symptoms in men who have been treated for benign prostatic hyperplasia (BPH) with tamsulosin...

Detailed Description

Study drugs are administered for 14 weeks in total, including a 2-week run-in period (single blind) and a 12-week treatment period (double blind). After written informed consent, study drugs for the r...

Eligibility Criteria

Inclusion

  • Patients with benign prostatic hypertrophy who have been treated with tamsulosin for at least 6 weeks
  • Patients with urgency episodes and frequent micturitions
  • Written informed consent has been obtained
  • Uroflowmetry-Q max ≥ 5 mL/sec, and Post Void Residual Volume \< 50 mL

Exclusion

  • Patients with suspected symptoms of OAB whose onset is only transient (drug-induced, psychogenic, etc.)
  • Patients with obvious stress urinary incontinence
  • Patients with complications or who have a past history of a bladder tumor
  • Patients with urethral stricture or bladder neck stenosis
  • Patients with a history of surgery causing damage to the pelvic plexus
  • Patients with history of hypersensitivity to α receptor blockers, a/b receptor blockers, or anticholinergic drugs
  • Patients with orthostatic hypotension, ulcerative colitis, hyperthyroidism, dementia or cognitive dysfunction, Parkinson's disease, or cerebrovascular disorder

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2010

Estimated Enrollment :

638 Patients enrolled

Trial Details

Trial ID

NCT00771394

Start Date

October 1 2008

End Date

January 1 2010

Last Update

February 15 2013

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Chugoku, Japan

2

Chūbu, Japan

3

Hokkaido, Japan

4

Kansai, Japan